Early and efficient detection of the Delta and Omicron variantso f SARS-CoV-2 through RT-qPCR screening
Bioquímica y Patología Clínica (ByPC)
pdf (Spanish)
html (Spanish)

Keywords

SARS-CoV 2
variants
deletions
sequencing
qPCR

How to Cite

Early and efficient detection of the Delta and Omicron variantso f SARS-CoV-2 through RT-qPCR screening. (2022). Biochemistry and Clinical Pathology Journal, 86(3), 33-38. https://doi.org/10.62073/bypc.v86i3.227

Abstract

Introduction. During the COVID-19 pandemic, the rise of so-called variants of concern (VOCs) has been a recurring problem. The gold standard approach for the identification of new and current variantsis genomic sequencing. However, the capacity of the genomic surveillance system is limited and prior screening strategies are required for sample selection. Objectives. To design, validate and apply Reverse-Transcription quantitative Polymerase Chain Reaction (RT-qPCR) strategies for the screening of the Delta and Omicron variants, as well as for the detection of eventual emergence of new variants. Materials and methods. Specific oligonucleotides (primers and probes) were designed to allow the discrimination between the different variants of SARS-Cov2, by hybridizing with regions corresponding to specific deletions. Amplification and melting assays of fluorescent probes were used and validated with samples of different variants. Results. The assays allowed identifying VOCs quickly and efficiently, using standard methodologies in molecular diagnostic laboratories. Variant assignment with this method was in complete agreement with data from sequencing. Conclusions. The protocols validated in this work allowed the early detection of the Delta and Omicron variants in the province of San Luis, as well as in other jurisdictions of Argentina where the methodology was transferred.

pdf (Spanish)
html (Spanish)

References

Brown KA, Gubbay J, Hopkins J, Patel S, Buchan SA, Daneman N, et al. S-Gene Target Failure as a Marker of Variant B.1.1.7 Among SARS-CoV-2 Isolates in the Greater Toronto Area, December 2020 to March 2021. JAMA. 2021;325 (20):2115-6.

Ambrosis N, Aispuro PM,Belhart K, Bottero D, Crisp RL,Dansey MV, et al. Active Surveillance of Asymptomatic, Presymptomatic, and Oligosymptomatic SARS-CoV-2-Infected Individuals in Communities Inhabiting Closed or Semi-closed Institutions.Front. Med.2021; 8:e640688.

Marceca F, Rocha Viegas L, Pregi N, Barbas MG, Hozbor DF, Pecci A, et al. Pool Strategy for Surveillance Testing of SARS-CoV-2. Science Review from the end of the world. 2021;2(2):41-54.

Mahase E. Omicron sub-lineage BA. 2 may have “substantial growth advantage,” UKHSA reports. BMJ 2022; 376:o263.

Abbas Q, Kusakin A, Sharrouf K, Jyakhwo S, Komissarov AS. Follow-up investigation and detailed mutational characterization of the SARSCoV-2 Omicron variant lineages (BA. 1, BA. 2, BA. 3 and BA. 1.1). bioRxiv. 2022.

Wei C, Shan K-J, Wang W, Zhang S, Huan Q, Qian W. Evidence for a mouse origin of the SARS-CoV-2 Omicron variant. JGG. 2021;48:1111-1121.

Kuchipudi SV, Surendran-Nair M, Ruden RM, Yon M, Nissly RH, Vandegrift KJ, et al. Multiple spillovers from humans and onward transmission of SARS-CoV-2 in white-tailed deer. PNAS. 2022;119(6):e2121644119.